A new home for world-leading neuroscience
Today, we are internationally recognized for our groundbreaking work in multiple sclerosis, stroke, and Parkinson’s, with patients from all over seeking our expertise.
With a new, dedicated hub for one of the strongest research and care teams in the world, we’ll see even more breakthroughs in acute neurology, neurosurgery, epilepsy, multiple sclerosis, stroke, and Parkinson’s.
Here’s just one example where integrating research and care has allowed us to improve and save lives:
In 2001, John Chafe became the second person in a world-first clinical trial of its kind that virtually eliminated any new MS activity and stabilized his disease.